Literature DB >> 22425905

Evaluation of antiulcer activity of chromanone fraction from Calophyllum brasiliesnse Camb.

Larissa Maria Scalon Lemos1, Thaís Bezerra Martins, Guilherme Henrique Tanajura, Vanessa Fátima Gazoni, Josiane Bonaldo, Claudia Léia Strada, Marcos Gabriel da Silva, Evandro Luiz Dall'oglio, Paulo Teixeira de Sousa Júnior, Domingos Tabajara de Oliveira Martins.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Calophyllum brasiliense Camb. (Clusiaceae), popularly known as 'guanandi', is found in the tropical areas and swampy lands. The latex exuding from its bark is used in the treatment of gastric ulcer in folk medicine. Several active compounds have been isolated from its stem bark among them, are the chromanone acids. Therefore, this study aimed to evaluate antiulcer activity and probable mechanism(s) of action of a fraction containing a mixture of chromanone acids (BI), derived by column chromatography fractionation of the hexane extract of the stem bark of Calophyllum brasiliense (HECb), using experimental in vitro and in vivo models.
MATERIALS AND METHODS: Ulcer was induced by oral administration of ethanol (75%, v/v) and indomethacin (50mg/kg). Malondialdehyde, reduced glutathione and catalase activity was measured in stomach tissue after ethanol induced ulcer. In order to evaluate the effect of BI on nitric oxide, ulcer was induced by ethanol in l-NAME pretreated animals. Anti-Helicobacter pylori activity was verified in disk diffusion and broth microdilution in vitro assays, using cagA+ and vacA+ Helicobacter pylori strains.
RESULTS: BI prevented the gastric ulceration caused by ethanol and indomethacin treatments. Its gastroprotective mechanism in ethanol-induced ulcer was partly due to reduction of MDA and CAT levels in the gastric tissue. BI did not affect the GSH levels and its gastroprotective effect was not reversed by pretreatment with l-NAME. BI showed anti-Helicobacter pylori in the both assays.
CONCLUSION: The results indicate that BI is partly responsible for the HECb antiulcer and anti-Helicobacter pylori effects.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22425905     DOI: 10.1016/j.jep.2012.03.006

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  7 in total

Review 1.  Nontraditional therapies to treat Helicobacter pylori infection.

Authors:  Morris O Makobongo; Jeremy J Gilbreath; D Scott Merrell
Journal:  J Microbiol       Date:  2014-03-29       Impact factor: 3.422

Review 2.  Evidence-based assessment of proton-pump inhibitors in Helicobacter pylori eradication: a systematic review.

Authors:  Vinayak Nagaraja; Guy D Eslick
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

Review 3.  Overview of the phytomedicine approaches against Helicobacter pylori.

Authors:  Filipa F Vale; Mónica Oleastro
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

4.  Hexane Extracts of Calophyllum brasiliense Inhibit the Development of Gastric Preneoplasia in Helicobacter felis Infected INS-Gas Mice.

Authors:  Larissa M S Lemos; Fabio Miyajima; Geovane R C Castilho; Domingos Tabajara O Martins; D Mark Pritchard; Michael D Burkitt
Journal:  Front Pharmacol       Date:  2017-02-27       Impact factor: 5.810

Review 5.  Plants against Helicobacter pylori to combat resistance: An ethnopharmacological review.

Authors:  Doha Abou Baker
Journal:  Biotechnol Rep (Amst)       Date:  2020-05-21

6.  Banhabaekchulchunma-tang, a traditional herbal formula attenuates absolute ethanol-induced gastric injury by enhancing the antioxidant status.

Authors:  In-Sik Shin; Woo-Young Jeon; Hyeun-Kyoo Shin; Sin-Woo Cha; Mee-Young Lee
Journal:  BMC Complement Altern Med       Date:  2013-07-12       Impact factor: 3.659

Review 7.  Phytochemicals in Helicobacter pylori Infections: What Are We Doing Now?

Authors:  Bahare Salehi; Farukh Sharopov; Miquel Martorell; Jovana Rajkovic; Adedayo Oluwaseun Ademiluyi; Mehdi Sharifi-Rad; Patrick Valere Tsouh Fokou; Natália Martins; Marcello Iriti; Javad Sharifi-Rad
Journal:  Int J Mol Sci       Date:  2018-08-10       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.